Searched for
SHANGHVI FINANCE
Skyroot Aerospace, KreditBee among latest startups to enter unicorn clubIndia's startup scene is experiencing significant growth. Several new companies have achieved unicorn status, valued at over $1 billion. Sk...- Ram Shriram's Sherpalo Ventures to lead $60 million funding round in Skyroot; valuation hits $1.1 billionGIC, of Singapore, BlackRock, Greenko Group founders take part in round along with Sun Pharma founder Dilip Shanghvi family office as the 9...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Suzlon Energy shares fall over 3% after Dilip Shanghvi and Associates terminate 2020 pactShares of Suzlon Energy fell 3% to Rs 25 in Wednesday's trade on BSE after the Sun Pharma promoter Dilip Shanghvi and Associates decided to...
- Dilip Shanghvi & Associates terminate 2020 pact with Suzlon EnergyWith the termination of the agreement, the investor group's nominee director on Suzlon's board, Hiten Timbadia, has also resigned with effe...
- Shanghvi Finance exits RBI's upper layer NBFC listA total of 15 NBFCs are part of the list, down from 16 when the RBI first released it in September 2022. The RBI did not give any reason fo...
- Shanghvi Finance raises stake in Sun PharmaShares of Sun Pharma ended up 6.6 per cent at Rs 393.35 on Tuesday.
- Firm on pharma, Dilip Shanghvi surrenders NBFC licenceRBI puts on hold Shanghvi Finance's request for core investment company licence.
- Sudhir Vaila looks to raise up to Rs 500 croreDeutsche Bank along with another foreign lender may extend the three-year credit expected to come from the lender’s overseas branch, two pe...
- There is no diversion of funds at all: Sudhir Valia, director, Sun PharmaSudhir Valia, brother-in-law of Sun Pharma promoter Dilip Shanghvi, in a telephonic chat with Divya Rajagopal, discusses the issues of Adit...
- Sun promoters pledged firm's shares for SurakshaShanghvi's brother-in-law and realty co owner Valia denies drugmaker stood guarantee for fundraising.
- Sun Pharma open to evaluating past decisions: Dilip ShanghviA WhatsApp forward leaked details of a report containing allegations of corporate governance improprieties
- Sun Pharma says open to evaluating certain business transactions if investors not comfortable with themAs of now the company has not received any query from Sebi with regard to whistleblower complaint, Sun Pharma Founder and MD Dilip Shanghvi...
- Dilip Shanghvi owns 3.8% of Unichem LabsShanghvi received nearly Rs 1,450 crore in dividends in the last five years from his Sun Pharma.
- Dilip Shanghvi, IDFC Bank, Telenor drop plans to set up payments bankThe decision to abandon plans to set up a payments bank was taken as the promoters felt that they lacked adequate physical presence in term...
- Sun Pharmaceuticals founder Dilip Shanghvi in talks to acquire stake in Suzlon EnergyDilip Shanghvi's brother-in-law Sudhir Valia will provide Rs 4,000 crore, which the debt-hit Suzlon will use to meet its working capital ne...
Load More
